Daiichi Sankyo and UMN Pharma enter into collaborative research agreement for Norovirus Vaccine
14 February 2014 | By Daiichi Sankyo Company
Norovirus is one of the leading causes of infectious gastroenteritis and the number of infected people reported is increasing both in Japan and globally...